Fig. 5From: RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivityLigand independent induction of RRM2, CDC6 and TOP2A in ESR1 mutant MCF7 cells. MCF7 WT, MCF7 Y537S, MCF7 D538G cells were synchronized for 3 days in phenol red free DMEM containing 5% CSS. MCF7 WT cells were either treated with (Veh) or estrogen (E2) for 24 h. Expression level of RRM2, CDC6, and TOP2A was evaluated by qRT-PCR and normalised against RPLP0. Data presented as mean ± S.D of three independent experiments. *p < 0.05, two-tailed unpaired t-test compared with vehicle treated MCF7 WT cellsBack to article page